Spots Global Cancer Trial Database for breast ductal carcinoma in situ
Every month we try and update this database with for breast ductal carcinoma in situ cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction | NCT06195306 | Breast Atypical... Breast Carcinom... Breast Ductal C... Breast Lobular ... | Biospecimen Col... Mammography Omega-3-Acid Et... Questionnaire A... Random Periareo... Tamoxifen | 45 Years - 65 Years | National Cancer Institute (NCI) | |
| A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ | NCT04144023 | Breast Ductal C... | Granulocyte-Mac... Multi-epitope H... Therapeutic Con... Echocardiograph... Biospecimen Col... Biopsy | 18 Years - | Mayo Clinic | |
| EMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast Cancer | NCT05086705 | Breast Carcinom... Breast Ductal C... Breast Lobular ... Hot Flashes | EMBr Wave Questionnaire A... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery | NCT04169542 | Breast Ductal C... COVID-19 Infect... Hereditary Brea... Invasive Breast... | Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer | NCT03323658 | Breast Atypical... Breast Atypical... Breast Ductal C... Breast Lobular ... Invasive Breast... | Bexarotene Questionnaire A... | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy | NCT00769379 | Breast Ductal C... | Laboratory Biom... Trastuzumab Whole Breast Ir... | 18 Years - | National Cancer Institute (NCI) | |
| A Patient Navigation Program for Addressing Disparities in Breast Cancer Care | NCT06350500 | Breast Carcinom... Breast Ductal C... | Patient Navigat... Questionnaire | 18 Years - | Roswell Park Cancer Institute | |
| Effect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast Cancer | NCT04022772 | Breast Carcinom... Breast Ductal C... Invasive Breast... Recurrent Breas... | Best Practice Medical Chart R... Quality-of-Life... Questionnaire A... Supportive Care | 18 Years - | M.D. Anderson Cancer Center | |
| Intermittent Fasting for the Improvement of Outcomes in Patients With Stage I-III Breast Cancer Receiving Chemotherapy Before Surgery | NCT05327608 | Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Breast Ductal C... HER2 Negative B... Hormone Recepto... Invasive Breast... | Short-Term Fast... | 18 Years - | Thomas Jefferson University | |
| Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer | NCT02636582 | Breast Ductal C... | Laboratory Biom... Nelipepimut-S P... Sargramostim Surgical Proced... | 18 Years - | National Cancer Institute (NCI) | |
| Intermittent Fasting for the Improvement of Outcomes in Patients With Stage I-III Breast Cancer Receiving Chemotherapy Before Surgery | NCT05327608 | Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Breast Ductal C... HER2 Negative B... Hormone Recepto... Invasive Breast... | Short-Term Fast... | 18 Years - | Thomas Jefferson University | |
| Effect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast Cancer | NCT04022772 | Breast Carcinom... Breast Ductal C... Invasive Breast... Recurrent Breas... | Best Practice Medical Chart R... Quality-of-Life... Questionnaire A... Supportive Care | 18 Years - | M.D. Anderson Cancer Center | |
| Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery | NCT03317405 | Breast Ductal C... Breast Lobular ... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | Endoxifen Hydro... Placebo Adminis... Questionnaire A... | 18 Years - | National Cancer Institute (NCI) | |
| Metformin and Nightly Fasting in Women With Early Breast Cancer | NCT05023967 | Anatomic Stage ... Anatomic Stage ... Breast Ductal C... Invasive Breast... | Biospecimen Col... Extended Releas... Monitoring Nutritional Ass... Short-Term Fast... | 18 Years - | M.D. Anderson Cancer Center | |
| Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy | NCT00769379 | Breast Ductal C... | Laboratory Biom... Trastuzumab Whole Breast Ir... | 18 Years - | National Cancer Institute (NCI) | |
| Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer | NCT05941520 | Breast Atypical... Breast Carcinom... Breast Ductal C... Breast Lobular ... | Acolbifene Hydr... Biospecimen Col... Mammography Random Periareo... Tamoxifen | 35 Years - | National Cancer Institute (NCI) | |
| Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer | NCT03323658 | Breast Atypical... Breast Atypical... Breast Ductal C... Breast Lobular ... Invasive Breast... | Bexarotene Questionnaire A... | 18 Years - | National Cancer Institute (NCI) | |
| Effect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast Cancer | NCT04022772 | Breast Carcinom... Breast Ductal C... Invasive Breast... Recurrent Breas... | Best Practice Medical Chart R... Quality-of-Life... Questionnaire A... Supportive Care | 18 Years - | M.D. Anderson Cancer Center | |
| Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer | NCT02876640 | Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Breast Ductal C... Early Stage Bre... Invasive Breast... | Biospecimen Col... Retinoid 9cUAB3... Therapeutic Con... | 18 Years - | National Cancer Institute (NCI) | |
| Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer | NCT05340673 | Breast Ductal C... Invasive Breast... | Agent Affecting... Petrolatum-Mine... Quality-of-Life... Questionnaire A... | 18 Years - | City of Hope Medical Center | |
| Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ | NCT04046159 | Breast Ductal C... | Low-dose tamoxi... Whole breast ra... | 40 Years - | National Taiwan University Hospital | |
| Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction | NCT06195306 | Breast Atypical... Breast Carcinom... Breast Ductal C... Breast Lobular ... | Biospecimen Col... Mammography Omega-3-Acid Et... Questionnaire A... Random Periareo... Tamoxifen | 45 Years - 65 Years | National Cancer Institute (NCI) | |
| Metformin and Nightly Fasting in Women With Early Breast Cancer | NCT05023967 | Anatomic Stage ... Anatomic Stage ... Breast Ductal C... Invasive Breast... | Biospecimen Col... Extended Releas... Monitoring Nutritional Ass... Short-Term Fast... | 18 Years - | M.D. Anderson Cancer Center | |
| A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ | NCT04144023 | Breast Ductal C... | Granulocyte-Mac... Multi-epitope H... Therapeutic Con... Echocardiograph... Biospecimen Col... Biopsy | 18 Years - | Mayo Clinic | |
| Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer | NCT01272037 | Breast Ductal C... Invasive Breast... Multicentric Br... Multifocal Brea... Synchronous Bil... | Anastrozole Exemestane Laboratory Biom... Letrozole Quality-of-Life... Systemic Chemot... Tamoxifen Citra... | 18 Years - | National Cancer Institute (NCI) | |
| Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer | NCT02876640 | Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Breast Ductal C... Early Stage Bre... Invasive Breast... | Biospecimen Col... Retinoid 9cUAB3... Therapeutic Con... | 18 Years - | National Cancer Institute (NCI) | |
| An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer Survivors | NCT05012176 | Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Breast Ductal C... Invasive Breast... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... | Behavioral Inte... Behavioral Inte... Quality-of-Life... Questionnaire A... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Effect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast Cancer | NCT04022772 | Breast Carcinom... Breast Ductal C... Invasive Breast... Recurrent Breas... | Best Practice Medical Chart R... Quality-of-Life... Questionnaire A... Supportive Care | 18 Years - | M.D. Anderson Cancer Center | |
| Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer | NCT02876640 | Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Breast Ductal C... Early Stage Bre... Invasive Breast... | Biospecimen Col... Retinoid 9cUAB3... Therapeutic Con... | 18 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
